Live symbol workspace

601005.SS market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

AI dossier is still gathering data for this asset

We publish verified AI sentiment once enough provider calls have been scored against real market moves for this symbol.

See our verified AI accuracy leaderboard →

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

601005.SS News Intelligence (1 articles)

AI-curated news influencing 601005.SS price, sentiment, and trend

Explore All 601005.SS News with AI Analysis

Economy

2 hours, 35 minutes ago

SBP Group Eyes Innovation as It Shifts Beyond Generics

SBP Group CEO Eric Tse discusses his outlook for China's healthcare sector and how one of China's old-guard pharmaceutical players …

Impact on 601005.SS: The news may have a positive impact on SBP Group's stock price …

SBP Group, a Chinese pharmaceutical company, is shifting its focus from generics to innovation and … Medium (60%)

View full analysis →

Bloomberg 60% confidence